openPR Logo
Press release

Nitric Oxide Asthma Testing Market Set to Witness Steady Growth with a 4.50% CAGR Through 2031, Insights from Persistence Market Research

01-28-2025 07:39 AM CET | Health & Medicine

Press release from: Persistence Market Research

Nitric Oxide Asthma Testing Market Set to Witness Steady Growth

The global Nitric Oxide Asthma Testing Market is on the verge of steady and sustained growth, expected to expand at a 4.50% Compound Annual Growth Rate (CAGR) from 2024 to 2031. This growth trajectory is attributed to the increasing awareness about the early diagnosis and management of asthma, along with advancements in testing technologies. As asthma remains one of the most common chronic diseases worldwide, affecting millions of people across various age groups, the demand for effective and non-invasive diagnostic tools such as Nitric Oxide Asthma Testing continues to rise.

๐ˆ๐ง ๐š ๐ง๐ฎ๐ญ๐ฌ๐ก๐ž๐ฅ๐ฅ, ๐ญ๐ก๐ž ๐๐ž๐ซ๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ข๐ฌ ๐š ๐ฆ๐ฎ๐ฌ๐ญ-๐ซ๐ž๐š๐ ๐Ÿ๐จ๐ซ ๐ฌ๐ญ๐š๐ซ๐ญ-๐ฎ๐ฉ๐ฌ, ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ, ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐จ๐ซ๐ฌ, ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก๐ž๐ซ๐ฌ, ๐œ๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐š๐ง๐ญ๐ฌ, ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ฌ๐ญ๐ฌ, ๐š๐ง๐ ๐š๐ฅ๐ฅ ๐ญ๐ก๐จ๐ฌ๐ž ๐ฐ๐ก๐จ ๐š๐ซ๐ž ๐ฅ๐จ๐จ๐ค๐ข๐ง๐  ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ญ๐ก๐ข๐ฌ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ. ๐†๐ž๐ญ ๐š ๐ ๐ฅ๐š๐ง๐œ๐ž ๐š๐ญ ๐ญ๐ก๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ - https://www.persistencemarketresearch.com/samples/34454

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

Asthma, a chronic inflammatory disease of the airways, has long been a major health concern. Early diagnosis and regular monitoring are key to controlling the condition and reducing the incidence of severe asthma attacks. Nitric oxide (NO) testing, specifically fractional exhaled nitric oxide (FeNO) testing, has gained significant attention as a method for diagnosing asthma and assessing airway inflammation, which is a hallmark of the disease. The FeNO test measures the levels of nitric oxide in a patient's exhaled breath, providing real-time insights into the status of airway inflammation and aiding clinicians in tailoring more effective asthma management strategies.

The Nitric Oxide Asthma Testing Market has seen significant growth due to the increased demand for non-invasive, easy-to-use, and accurate diagnostic tools. FeNO testing is particularly beneficial in differentiating between allergic and non-allergic asthma, making it an essential tool in personalized asthma management.

๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐…๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐Ÿ๐จ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก

Growing Prevalence of Asthma: The rising global prevalence of asthma is one of the primary factors driving the demand for diagnostic solutions such as FeNO testing. According to the World Health Organization (WHO), over 262 million people worldwide suffer from asthma, and the number continues to rise. This surge in asthma cases, combined with growing awareness about the importance of early detection, is contributing to the market's expansion.

Advancements in Testing Technology: The development of more sophisticated FeNO testing devices that are user-friendly, portable, and accurate is contributing significantly to market growth. These innovations are not only improving the patient experience but also enhancing the precision and reliability of asthma diagnosis and management.

Rising Awareness and Acceptance: Increasing awareness among healthcare professionals and patients about the benefits of FeNO testing is driving market demand. Healthcare providers are increasingly adopting FeNO testing as part of their asthma management protocols, recognizing its value in determining the level of airway inflammation and adjusting treatment plans accordingly.

Government Initiatives and Funding: Various governments around the world are prioritizing asthma management and investing in initiatives that encourage the adoption of advanced diagnostic tools. This, in turn, is fueling the demand for FeNO testing in both developed and emerging markets.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

The Nitric Oxide Asthma Testing Market can be segmented based on technology, end-users, and geography.

Technology:

Portable Devices: Portable FeNO devices are becoming increasingly popular due to their convenience and ease of use. These devices allow for on-the-spot testing and are particularly valuable in both clinical and home settings, enabling continuous asthma monitoring.

Stationary Devices: Stationary devices are commonly used in hospital and clinical settings. These devices are often more advanced and provide highly accurate measurements of exhaled nitric oxide. They are typically used for more detailed and diagnostic purposes, such as identifying asthma subtypes or assessing treatment effectiveness.

End-Users:

Hospitals and Clinics: The healthcare sector remains the largest end-user of FeNO testing devices. These facilities benefit from the precision and efficiency that nitric oxide asthma testing offers, enabling better asthma management and improving patient outcomes.

Diagnostic Laboratories: Diagnostic labs use FeNO testing as a routine diagnostic tool to assess inflammation levels in asthma patients. This sector is experiencing growth due to the rising demand for advanced diagnostic services.
Home Care: With the rise of home-based healthcare solutions, FeNO testing devices are becoming increasingly available for home use. This offers patients the convenience of monitoring their condition from the comfort of their homes, while also reducing the need for frequent clinic visits.

Geography:

North America: North America holds the largest market share due to the high prevalence of asthma, along with well-established healthcare infrastructure and a high level of awareness about the benefits of FeNO testing.

Europe: Europe is also witnessing significant growth, driven by rising healthcare expenditures and a growing number of asthma-related cases. The region's supportive healthcare policies and adoption of advanced medical technologies further bolster market expansion.

Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth rate due to the increasing asthma burden and the expanding healthcare infrastructure. Moreover, governments in countries such as India and China are investing heavily in healthcare and medical technologies, which is creating lucrative opportunities for the FeNO testing market.

Latin America and the Middle East & Africa (MEA): Although the market in these regions is relatively nascent, the rising prevalence of asthma and healthcare investments are expected to drive steady growth in the coming years.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

The Nitric Oxide Asthma Testing Market is characterized by the presence of several key players who dominate the market. These players are focusing on research and development, technological advancements, and strategic partnerships to expand their market reach. Some of the key players in the market include:

Aerocrine AB (Acquired by Circassia Pharmaceuticals)
NuvoAir
Bedfont Scientific Ltd.
MediServe Solutions
Intermedic
Vitalograph Ltd.

These companies are continuously innovating and introducing new products to enhance the effectiveness and user-friendliness of FeNO testing devices. For instance, portable FeNO analyzers are becoming more compact and efficient, catering to the growing demand for at-home testing solutions.

๐‚๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ

While the market for Nitric Oxide Asthma Testing is experiencing significant growth, it is not without challenges. One of the key hurdles is the cost of advanced FeNO testing devices, which can be prohibitive for some healthcare providers and patients, especially in low-income regions. Additionally, there is a need for standardization in testing methods, as variability in results can sometimes complicate diagnosis and treatment plans.

Another challenge is the relatively low awareness of FeNO testing in some parts of the world, particularly in emerging markets where traditional asthma diagnosis methods still dominate. Overcoming these barriers will be essential for the continued growth of the market.

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

The future of the Nitric Oxide Asthma Testing Market looks promising, with several factors poised to drive growth in the coming years. As technology continues to evolve, we can expect even more innovative and accurate FeNO testing devices that will make asthma diagnosis faster and more efficient. Moreover, the increasing shift toward home-based healthcare and telemedicine will provide further growth opportunities for portable FeNO testing solutions.

The market is also expected to benefit from collaborations between healthcare providers, government organizations, and technology companies, which will facilitate the integration of FeNO testing into routine asthma management practices. Additionally, increasing efforts to raise awareness about the importance of early asthma diagnosis and management are expected to further boost market demand.

๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐ฌ๐ข๐จ๐ง

In conclusion, the Nitric Oxide Asthma Testing Market is positioned for substantial growth, with a projected CAGR of 4.50% through 2031. This growth is being fueled by the increasing prevalence of asthma, advancements in testing technology, and the rising demand for non-invasive and accurate diagnostic tools. With continued innovation and increased adoption across various healthcare settings, FeNO testing is set to play an integral role in the early diagnosis and management of asthma, improving patient outcomes and contributing to the overall improvement of global respiratory health.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐๐ž๐ซ๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nitric Oxide Asthma Testing Market Set to Witness Steady Growth with a 4.50% CAGR Through 2031, Insights from Persistence Market Research here

News-ID: 3836344 • Views: โ€ฆ

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers โ€ฆ
โžค Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance toโ€ฆ
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S โ€ฆ
โžค Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million inโ€ฆ
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr โ€ฆ
โžคOverview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. Accordingโ€ฆ
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health โ€ฆ
โžคOverview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gainedโ€ฆ

All 5 Releases


More Releases for FeNO

FeNO Breath Analyzer Market Outlook and Future Projections for 2030
The feno breath analyzer market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines theโ€ฆ
Handheld FeNO Breath Analyzers Market Trends, Demand, and Future Outlook
Exactitude Consultancy., Ltd. announces the release of the report "Global Handheld FeNO Breath Analyzers Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.โ€ฆ
FeNO Breath Analyzer market outstanding growth with a CAGR of 13.8% during 2023- โ€ฆ
The global FeNO Breath Analyzer market size was valued at USD 71 million in 2022 and is forecast to a readjusted size of USD 174.7 million by 2029 with a CAGR of 13.8% during review period. The global FeNO (Fractional exhaled Nitric Oxide) Breath Analyzer market is witnessing significant growth and innovation, driven by the increasing prevalence of respiratory diseases and the growing awareness regarding personalized medicine. This press releaseโ€ฆ
China FeNO Testing Market Size Worth USD 66,564.09 million by 2030| China FeNO T โ€ฆ
A FeNO test or exhaled nitric oxide test can be used to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation in patients with allergic or eosinophilic asthma. FeNO testing is a quantitative, non-invasive, simple, and safe test that can be performed in primary care by a properly trained health care professional who is competent to deliver and interpret the results. The advantagesโ€ฆ
China FeNO Testing Market Forecast & Insight 2030
A FeNO test or exhaled nitric oxide test can be used to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation in patients with allergic or eosinophilic asthma. FeNO testing is a quantitative, non-invasive, simple, and safe test that can be performed in primary care by a properly trained health care professional who is competent to deliver and interpret the results. The advantagesโ€ฆ
FeNO Measuring Device Market Trends Analysis, Demand and Forecasts 2030
A recent market research report added to repository of Analytics Market Research is an in-depth analysis of Global & USA FeNO Measuring Device Market. On the basis of historic growth analysis and current scenario of FeNO Measuring Device market place, the report intends to offer actionable insights on Global & USA market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insightsโ€ฆ